Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Simmons

Showing results (21-30 of 209) with videos related to

Pageof 21
Sort By:
Journal of Virology|December 1, 1991
The ability of large T antigen to complex with p53 is necessary for the increased life span and partial transformation of human cells by simian virus 40J Y Lin, D T Simmons
Oncogene|August 1, 1993
p53 mutants with changes in conserved region II: three classes with differing antibody reactivity, SV40 T antigen binding and ability to inhibit transformation of rat cellsF I Schmieg, D T Simmons
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1978
Common methionine-tryptic peptides near the amino-terminal end of primate papovavirus tumor antigensD T Simmons, M A Martin
Virology|May 1, 1988
Characterization of the in vitro interaction between SV40 T antigen and p53: mapping the p53 binding siteF I Schmieg, D T Simmons
Journal of Virology|November 1, 1984
Intracellular location and kinetics of complex formation between simian virus 40 T antigen and cellular protein p53F I Schmieg, D T Simmons
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|September 21, 2006
Electroincision of refractory esophagogastric anastomotic stricturesD T Simmons, T H Baron
Oncogene|March 1, 1991
Evidence that SV40 surface tumor antigen originates from the nucleus and cytoplasmJ M Boyd, D T Simmons
Biochemistry|January 30, 2010
The SV40 large T-antigen origin binding domain directly participates in DNA unwindingErin C Foster, Daniel T Simmons
The American Journal of Gastroenterology|May 11, 2007
pERCePtions on ERCP utilization in the United StatesDia T Simmons, Todd H Baron
Clinical Therapeutics|May 24, 2000
Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma. ALPHAGAN/XALATAN Study GroupS T Simmons, T W Samuelson
Pageof 21

Showing results (21-30 of 209) with videos related to

Sort By:
Pageof 21
Journal of Virology|December 1, 1991
The ability of large T antigen to complex with p53 is necessary for the increased life span and partial transformation of human cells by simian virus 40J Y Lin, D T Simmons
Oncogene|August 1, 1993
p53 mutants with changes in conserved region II: three classes with differing antibody reactivity, SV40 T antigen binding and ability to inhibit transformation of rat cellsF I Schmieg, D T Simmons
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1978
Common methionine-tryptic peptides near the amino-terminal end of primate papovavirus tumor antigensD T Simmons, M A Martin
Virology|May 1, 1988
Characterization of the in vitro interaction between SV40 T antigen and p53: mapping the p53 binding siteF I Schmieg, D T Simmons
Journal of Virology|November 1, 1984
Intracellular location and kinetics of complex formation between simian virus 40 T antigen and cellular protein p53F I Schmieg, D T Simmons
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|September 21, 2006
Electroincision of refractory esophagogastric anastomotic stricturesD T Simmons, T H Baron
Oncogene|March 1, 1991
Evidence that SV40 surface tumor antigen originates from the nucleus and cytoplasmJ M Boyd, D T Simmons
Biochemistry|January 30, 2010
The SV40 large T-antigen origin binding domain directly participates in DNA unwindingErin C Foster, Daniel T Simmons
The American Journal of Gastroenterology|May 11, 2007
pERCePtions on ERCP utilization in the United StatesDia T Simmons, Todd H Baron
Clinical Therapeutics|May 24, 2000
Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma. ALPHAGAN/XALATAN Study GroupS T Simmons, T W Samuelson
Pageof 21